An extension to the company’s Series A brings total funding to €23 million and clears the path for the first human trial of KUP101, a dual TLR agonist targeting solid tumours and drug-resistant in [...]
NAD plus is a popular supplement lauded for its reported anti-aging benefits, but does it really work? We asked the experts. Here’s what they said about the potential upsides and risks. [...]